96980 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interferons [IFN] IFN-gamma
ZIKV-BASED GENE DELIVERY SYSTEM
#2Enhanced adoptive cell therapy
#3THERAPEUTIC CYTOKINES AND METHODS
#4INTERFERON GAMMA VARIANTS AND ANTIGEN BINDING MOLECULES COMPRISING THESE
#5CYTOKINE COMPOSITIONS AND METHODS OF USE THEREOF
#6BLOCKADE OF CD3 EXPRESSION AND CHIMERIC ANTIGEN RECEPTORS FOR IMMUNOTHERAPY
#7Methods and compositions for improving the immune response against viral pathogens
#8EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY
#9GAMMA DELTA T CELL COMPOSITIONS AND METHODS OF USE
#10MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#11COMPOSITIONS AND METHODS FOR VIRAL VECTORS
#12POLYMER ENGINEERED FORMS OF INTERFERON-GAMMA AND METHODS OF USE
#13METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS
#14CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER
#15ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents
#16THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR
#17SYSTEMS OF ENGINEERED RECEPTORS TARGETING PSMA AND CA9
#18MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#19FUSION PROTEIN OF INTERFERON (IFN) AND ANTI-PD-L1 ANTIBODY AND USE THEREOF
#20CYTOKINE COMPOSITIONS AND METHODS OF USE THEREOF
#21METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#22SPLIT HUMAN IFN-GAMMA AND TNF-ALPHA CONSTRUCTS AND USES THEREOF
#23IMMUNOMODULATORY MOLECULES AND USES THEREOF
#24CAR T CELL THERAPY AND IFN GAMMA
#25Rapamycin and Cell Therapy
#26METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS
#27ATP-dependent agonists of immune cells function as anticancer agents
#28IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF
#29COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS
#30PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES
#31BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#32IMMUNOGLOBULIN FUSION PROTEINS
#33IMMUNOGLOBULIN FUSION PROTEINS AND USES THEREOF
#34PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES
#35STING LEVELS AS A BIOMARKER FOR CANCER IMMUNOTHERAPY
#36MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHOD
#37METHODS AND COMPOSITIONS COMPRISING FUSION PROTEINS FOR THE IDENTIFICATION OF IMMUNOTHERAPY CELLS
#38IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES
#39EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY
#40VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER
#41ENHANCED-AFFINITY ANTI-ECM NANOBODY-CYTOKINE FUSIONS AND THEIR APPLICATIONS
#42SEPARATION MOIETIES AND METHODS OF USE THEREOF
#43VIRAL VECTORS EXPRESSING THERAPEUTIC PROTEINS SPECIFICALLY IN MYELOID CELLS AND MICROGLIA
#44Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor Microenvironment
#45CHIMERIC ANTIGEN RECEPTOR, MACROPHAGE EXPRESSING SAME, METHOD FOR ADJUSTING MACROPHAGE POLARIZATION, AND USE THEREOF
#46MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
#47IMMUNOMODULATORY POLYNUCLEOTIDES AND USES THEREOF
#48PROPROTEINS AND METHODS OF USE THEREOF
#49METHODS OF TREATMENT AND RELATED COMPOSITIONS
#50MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF
#51ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#52PROPROTEINS AND METHODS OF USE THEREOF
#53Macrophage CAR (MOTO-CAR) In Immunotherapy
#54Modified Cell Expressing Therapeutic Agent and Uses thereof
#55Masked activatable interferon constructs
#56Methods of treatment and related compositions
#57Separation moieties and methods of use thereof
#58TARGETED DELIVERY OF IFN GAMMA USING ANTIBODY FUSION PROTEINS
#59NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR
#60Modified Cell Expansion and Uses Thereof
#61COMPOSITIONS AND METHODS RELATING TO C5L2
#62Modified Cell Expressing Therapeutic Agent and Uses thereof
#63TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF
#645T4 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#65Methods for the production of therapeutic, diagnostic, or research antibodies
#66INTERFERON-GAMMA BIASED AGONISTS
#67CANCER TARGETS AND USES THEREOF
#68Salt-tolerant , method of culturing salt-tolerant , and immunostimulant
#69Methods for inducing an immune response by administering activated mesenchymal stem cells
#70Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression
#71Modified Cell Expressing Therapeutic Agent and Uses thereof
#72Fusion protein of interferon (IFN) and anti-PD-L1 antibody and use thereof
#73NK CELL EXPANSION AND USES THEREOF
#74SEPARATION MOIETIES AND METHODS OF USE THEREOF
#75METHOD AND SYSTEM FOR SCREENING ANTI-TUMOUR SUBSTANCES
#76PLASMID CONSTRUCTS FOR HETEROLOGOUS PROTEIN EXPRESSION AND METHODS OF USE
#77Cytokine fusion proteins
#78STING levels as a biomarker for cancer immunotherapy
#79METHOD FOR IMMUNOTHERAPY DRUG TREATMENT
#80MULTIFUNCTIONAL MOLECULES AND USES THEREOF
#81Exosomes for immuno-oncology and anti-inflammatory therapy
#82METHODS AND SYSTEMS FOR IDENTIFICATION AND TREATMENT OF PATHOLOGICAL NEURODEGENERATION AND AGE-RELATED COGNITIVE DECLINE
#83Enhanced adoptive cell therapy
#84Method of treating glioblastoma multiforme
#85Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
#86PROPROTEINS AND METHODS OF USE THEREOF
#87LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME
#88NK OR T CELLS AND USES THEREOF
#89Use of lambda interferons in the treatment of obesity-related disorders and related diseases
#90Modified cell expressing therapeutic agent and uses thereof
#91Type I and type III interferon fusion molecules and methods for use thereof
#92Targeted mutant interferon-gamma and uses thereof
#93PANTIDS FOR TREATMENT OF AUTOIMMUNE DISORDERS
#94COMPOSITION FOR INCREASING EXPRESSION LEVEL OF INTERFERON IN ANIMAL CELLS USING PLANT-DERIVED DNA DEMETHYLASE, ANTIVIRAL COMPOSITION, AND METHOD USING SAME
#95Immunomodulatory polynucleotides and uses thereof
#96Interferon Analogs
#97TISSUE-BASED BIOLOGICS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS
#98METHODS OF TREATING MULTIPLE SCLEROSIS USING AUTOLOGOUS T CELLS
#99Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#100CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#101Methods of treating cancer
#102Exosomes for immuno-oncology and anti-inflammatory therapy
#103COMPOSITIONS AND METHODS RELATING TO C5L2
#104GENE THERAPY VECTORS AND CYTOSINE DEAMINASES
#105Plasmid constructs for heterologous protein expression and methods of use
#106Anti-CSPG4 fusions with interferon for the treatment of malignancy
#107COMPOSITION FOR PROMOTING INTERFERON LAMBDA PRODUCTION AND PRODUCTION METHOD THEREFOR
#108Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
#109Methods for the production of therapeutic, diagnostic, or research antibodies
#110Methods of producing activated mesenchymal stem cells
#111NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR
#112Cysteine analogs of exendin-4
#113Interferon analogs
#114Expression of Mammalian Proteins in Pseudomonas Fluorescens
#115CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
#116CANCER TARGETS AND USES THEREOF
#117APOBEC3A CYTIDINE DEAMINASE INDUCED RNA EDITING
#118Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#119Co-expression plasmid
#120Cleavage-activatable interferon-alpha proprotein
#121Fusions of antibodies to CD38 and attenuated interferon alpha
#122Macrophage CAR (MOTO-CAR) in immunotherapy
#123Enhanced adoptive cell therapy
#124Epitope recognized by anti-interferon gamma autoantibodies in patients with disseminated mycobacterial infections and the application therefor
#125Expression of mammalian proteins in
#126LONG ACTING PROTEINS AND PEPTIDES AND METHODS OF MAKING AND USING THE SAME
#127Surface-binding peptide
#128Immunoglobulin fusion proteins and uses thereof
#129CANCER TARGETS AND USES THEREOF
#130Method for determining site having N-linked sugar chain added thereto or proportion of said addition
#131Interferon-gamma release assays for diagnosis of invasive fungal infections
#132Interferon Analogs
#133TYPE I INTERFERON MIMETICS AS THERAPEUTICS FOR CANCER, VIRAL INFECTIONS, AND OTHER DISEASES
#134Anti-CSPG4 fusions with interferon for the treatment of malignancy
#135CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
#136Immunoconjugates for the treatment of tumours
#137Immunomodulatory peptides and methods of use thereof
#138Enhanced adoptive cell therapy
#139Engineered antibody-interferon fusion molecules for treatment of autoimmune diseases
#140Soluble notch receptor proproteins and methods of use thereof
#141Chinese hamster ovary cell lines
#142NH2-terminal glutamine modified cysteine variants of interferon gamma
#143Fusions of antibodies to CD38 and attenuated interferon alpha
#144Gene therapy vectors and cytosine deaminases
#145Suppressor of the endogenous interferon-gamma
#146DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#147Method for attenuating immune response using mesenchymal stem cells and cytokines
#148POLYMERIC CONJUGATES AND METHODS OF PREPARING THE SAME
#149Gelsolin stimulation of blood samples using gold particles
#150Hyaluronic acid-protein conjugates and method for preparing same
#151Anticancer fusion protein comprising TRAIL and interferon
#152Interferon analogs
#153Peptides for active anti-cytokine immunization
#154IFN-GAMMA INHIBITORS IN THE TREATMENT OF MOTONEURON DISEASES
#155Peptides for active anti-cytokine immunization
#156Immunostimulatory compositions and uses thereof
#157PEPTIDE FRACTIONS PROMOTING GROWTH AND SYNTHESIS OF DESIRED PRODUCT(S) INTO CELL AND/OR TISSUE CULTURE
#158Inhibitor of Endogenous Human Interferon-gamma
#159SINGLE CHAIN FC TYPE III INTERFERONS AND METHODS OF USING SAME
#160ALLOGENEIC VACCINE AND METHODS TO SYNTHESIZE SAME
#161Cysteine variants of interferon gamma
#162Inhibitor of Endogenous Human Interferon-Gamma
#163Gene therapy vectors and cytosine deaminases
#164Chinese hamster ovary cell lines
#165Protein formulation
#166Peptides for active anti-cytokine immunization
#167ALLOGENEIC VACCINE AND METHODS TO SYNTHESIZE SAME
#168SUPPERSSOR OF THE ENDOGENOUS INTERFERON-GAMMA
#169HYPERGLYCOSYLATED POLYPEPTIDE VARIANTS AND METHODS OF USE
#170Compositions and methods for treatment of angiogenesis in pathological lesions
#171Immunoconjugates for the treatment of tumours
#172Animal models for demyelination disorders
#173HUMAN INTERFERON-GAMMA (INFGAMMA) VARIANTS
#174Protease activatable interferon alpha proprotein
#175MODIFIED CYTOKINES FOR USE IN CANCER THERAPY
#176Viral particles encoding multifunctional cytokines
#177Inhibitor of endogenous human interferon-gamma
#178Peptides for active anti-cytokine immunization
#179Methods of making proteins and peptides containing a single free cysteine
#180Methods for protein refolding
#181Multifunctional Cytokines
#182IRX-2 modified manufacturing process
#183Inhibitor of endogenous human interferon-gamma
#184Compositions and methods for RNA interference with sialidase expression and uses thereof
#185Kit containing stem cells and cytokines for use in attenuating immune responses
#186Peptide fractions promoting growth and synthesis of desired product(S) into cell and/or tissue culture
#187DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#188Immunostimulatory compositions and uses thereof
#189Cysteine variants of interferon gamma
#190Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#191Peptides for active anti-cytokine immunization
#192Cysteine variants of interferon-gamma
#193Method for treating asthma and chronic obstructive pulmonary disease (COPD) comprising administering FGF2
#194Immunostimulatory compositions and uses thereof
#195Animal models for demyelination disorders
#196Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal
#197Rational Design and Engineering of Proteins and Peptides for Immunomodulation
#198Compositions and methods for cancer immunotherapy
#199Multifunctional cytokines
#200Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors
#201Modified cytokines for use in cancer therapy
#202Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
#203Erythropoietin: remodeling and glycoconjugation of erythropoietin
#204TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH IFN-GAMMA INHIBITORS
#205Novel IFNgamma-like polypeptides
#206Remodeling and glycoconjugation of peptides
#207Animal models for demyelination disorders
#208Methods for treating demyelination disorders
#209Interferon-IgG fusion
#210Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
#211Peptides for active anti-cytokine immunization
#212Expression of mammalian proteins in
#213Hyperglycosylated polypeptide variants and methods of use
#214Method for producing target proteins by deleting or amplifying and/or gene coding for inclusion body-associated proteins
#215Modified cytokines for use in cancer therapy
#216Full-length interferon gamma polypeptide variants
#217Antagonist peptides to the C5A chemotactic function of vitamin D binding protein
#218Expression of mammalian proteins in
#219Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
#220Nanogene therapy for cell proliferation disorders
#221Modified cytokines for use in cancer therapy
#222Agents and methods for promoting bone growth
#223Immunoglobulin chimeric monomer-dimer hybrids
#224Allogeneic vaccine and methods to synthesize same
#225Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression
#226Cysteine substitution variants of beta interferon
#227COOH-terminally added cysteine variant of the beta interferon
#228S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants
#229Chemically modified cytokines
#230Allogeneic vaccine and methods to synthesize same
#231Cysteine variants of erythropoietin
#232Pharmaceutical compositions of glycoconjugates
#233Cysteine variants of erythropoietin
#234Fusions of cytokines and tumor targeting proteins
#235Multifunctional cytokines
#236Method for recovering proteins from the interstitial fluid of plant tissues
#237Immunoconjugates for the treatment of tumours
#238Compositions and methods for enhancing immune responses mediated by antigen-presenting cells